Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
27/05/2026 12:57
BRIEF-HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen May 27 (Reuters) - HCW Biologics Inc HCWB.O:
EXERCISED OPTION TO REGAIN FULL RIGHTS FOR TWO COMMERCIAL-READY REAGENTS FROM WUGEN
BUYS RIGHTS FOR NO COST AND RETAINS 2.2 MILLION WUGEN SHARES
Source text: ID:nGNX5bDRx4
Further company coverage: HCWB.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: Hcw Biologics Maintains Momentum Toward Completion Of Ind Application For Clinical Study To Evaluate Lead T-Cell Engager In Solid Tumors
Brief: HCW Biologics Registers Resale Of Up To 1.81 Mln Shares Of Common Stock By Selling Stockholder- SEC Filing
NASDAQ RESUMED AT 10:34 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:29 AM
NASDAQ RESUMED AT 10:29 AM